Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbingdon Healt. Regulatory News (ABDX)

Share Price Information for Abingdon Healt. (ABDX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.75
Bid: 10.00
Ask: 11.50
Change: 0.00 (0.00%)
Spread: 1.50 (15.00%)
Open: 10.75
High: 10.75
Low: 10.75
Prev. Close: 10.75

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Award of Options under LTIP

24 Oct 2023 07:01

RNS Number : 0295R
Abingdon Health PLC
24 October 2023
 

Abingdon Health plc

("Abingdon" or "the Company")

 

Award of Options under LTIP

 

York, U.K. 24 October 2023: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality, rapid diagnostic tests, announces that, under the terms of the existing Long Term Incentive Plan established in December 2022 ("LTIP" or the "Plan"), the Company has awarded share options ("Options") over a total of 2,386,238 ordinary shares of 0.025 pence each ("Ordinary Shares") to certain directors and senior management, in order to incentivise and encourage retention in a manner that aligns with the interests of the Company's shareholders.

 

The Options are nil cost and will vest over a three-year vesting period. Vesting of the Options is conditional upon the business achieving certain challenging revenue, adj. EBITDA and total shareholder return criteria. The Options will become exercisable between 24 October 2026 and 24 October 2033.

 

The following directors and members of the senior management team (each a person discharging managerial responsibilities ("PDMR")) have been awarded options:

 

PDMR

Role

No. of new Options awarded under the LTIP

No. of existing Options under the LTIP

Total number of Options under the LTIP

 

Chris Yates

Chief Executive Officer

850,459

1,285,714

2,136,173

Chris Hand

Non-Executive Chairman

283,486

428,571

712,057

Mark Jones

Chief Operating Officer

401,376

600,000

1,001,376

Nina Garrett

Chief Technical Officer

337,156

515,000

852,156

Candice Vendetuolli

Head of QARA

183,486

285,714

469,200

Natalie Thrush

Head of HR

68,807

90,000

158,807

Liam Currivan

Head of Sales & Marketing

261,468

-

261,468

 

As a result of these changes, the Company now has outstanding options over 5,719,162 Ordinary Shares equal to approximately 4.7 per cent. of the Company's issued share capital.

 

Enquiries:

 

Abingdon Health plc

www.abingdonhealth.com/investors/

Chris Yates, Chief Executive Officer

Via Walbrook PR

Chris Hand, Non-Executive Chairman

 

 

 

 

 

Singer Capital Markets (Sole Broker and Nominated Adviser)

Tel: +44 (0)20 7496 3000

Peter Steel, Alex Bond, Jalini Kalaravy

 

 

 

Walbrook PR Limited

Tel: +44 (0)20 7933 8780 or abingdon@walbrookpr.com

Paul McManus / Phillip Marriage

Alice Woodings

Mob: +44 (0)7980 541 893 / +44 (0)7867 984 082

+44 (0)7407 804 654

 

About Abingdon Health plc

 

Abingdon Health is a leading lateral flow contract research (CRO) and contract development and manufacturing organisation ("CDMO") offering its services to an international customer base across industry sectors that include clinical, animal health, plant health, and environmental testing. Abingdon Health has the internal capabilities to take projects from initial concept through to routine and large-scale manufacturing; from "idea to commercial success."

The Company's CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health aims to support the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas such as infectious disease, clinical testing including companion diagnostics, animal health and environmental testing. Faster access to results allows for rapid decision making, targeted intervention and can support better outcomes. 

 

Abingdon Health's Abingdon Simply Test? range of self-tests is an ecommerce platform that offers a range of self-tests to empowers consumers to manage their own health and wellbeing. The Abingdon Simply Test? ecommerce site offers consumers a range of information to support them in making informed decisions on the tests available. In addition, the site provides Abingdon's contract services customers with a potential route to market for self-tests. The Abingdon Simply Test range is also sold through international distributors and through other channels in the UK and Ireland such as pharmacy chains.

 

Founded in 2008, Abingdon Health is headquartered in York, England.

 

For more information visit: www.abingdonhealth.com

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Chris Yates

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Abingdon Health plc

b)

 

LEI

 

213800XFI4WV3FBILO20

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 0.025 pence each

 

Identification code

GB00BLF79J41

b)

 

Nature of the transaction

 

 

Award of LTIP Options

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil-cost

850,459

d)

 

Aggregated information

N/A single transaction

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

23rd October 2023

f)

 

Place of the transaction

 

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Dr Chris Hand

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Non-Executive Chairman

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Abingdon Health plc

b)

 

LEI

 

213800XFI4WV3FBILO20

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 0.025 pence each

 

Identification code

GB00BLF79J41

b)

 

Nature of the transaction

 

 

Award of LTIP Options

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

283,486

d)

 

Aggregated information

N/A single transaction

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

23rd October 2023

f)

 

Place of the transaction

 

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Mark Jones

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Operating Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Abingdon Health plc

b)

 

LEI

 

213800XFI4WV3FBILO20

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 0.025 pence each

 

Identification code

GB00BLF79J41

b)

 

Nature of the transaction

 

 

Award of LTIP Options

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

401,376

d)

 

Aggregated information

N/A single transaction

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

23rd October 2023

f)

 

Place of the transaction

 

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Nina Garrett

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Technical Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Abingdon Health plc

b)

 

LEI

 

213800XFI4WV3FBILO20

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 0.025 pence each

 

Identification code

GB00BLF79J41

b)

 

Nature of the transaction

 

 

Award of LTIP Options

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

 Nil cost

337,156

d)

 

Aggregated information

N/A single transaction

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

23rd October 2023

f)

 

Place of the transaction

 

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Candice Vendetuolli

2

 

Reason for the notification

 

a)

 

Position/status

 

Head of QARA

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Abingdon Health plc

b)

 

LEI

 

213800XFI4WV3FBILO20

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 0.025 pence each

 

Identification code

GB00BLF79J41

b)

 

Nature of the transaction

 

 

Award of LTIP Options

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

183,486

d)

 

Aggregated information

N/A single transaction

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

23rd October 2023

f)

 

Place of the transaction

 

Outside a trading venue

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Natalie Thrush

2

 

Reason for the notification

 

a)

 

Position/status

 

Head of HR

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Abingdon Health plc

b)

 

LEI

 

213800XFI4WV3FBILO20

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 0.025 pence each

 

Identification code

GB00BLF79J41

b)

 

Nature of the transaction

 

 

Award of LTIP Options

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

68,807

d)

 

Aggregated information

N/A single transaction

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

23rd October 2023

f)

 

Place of the transaction

 

Outside a trading venue

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Liam Currivan

2

 

Reason for the notification

 

a)

 

Position/status

 

Head of Sales & Marketing

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Abingdon Health plc

b)

 

LEI

 

213800XFI4WV3FBILO20

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 0.025 pence each

 

Identification code

GB00BLF79J41

b)

 

Nature of the transaction

 

 

Award of LTIP Options

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil cost

261,468

d)

 

Aggregated information

N/A single transaction

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

23rd October 2023

f)

 

Place of the transaction

 

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHMZMZGGFVGFZZ
Date   Source Headline
15th Jul 20247:00 amRNSChange of Nominated Adviser and Broker
9th Jul 20247:00 amRNSTrading Update
31st May 20247:00 amRNSTotal Voting Rights – 31 May 2024
15th May 20247:00 amRNSLaunch of the Saliva Pregnancy self-test in Boots
8th May 20247:00 amRNSChange of Nominated Adviser and Sole Broker
7th May 20247:00 amRNSAcquisition of IVDeology Holdings Limited
25th Mar 20247:00 amRNSDesign freeze completion & strategic partnership
20th Mar 20247:00 amRNSLaunch of OEM self-tests in Boots
15th Mar 20241:00 pmRNSCEO Interview
14th Mar 20247:00 amRNSInterim Results
11th Mar 20248:53 amRNSNotice of Results
11th Jan 20247:01 amRNSUpdate to Shareholder Concert Parties
11th Jan 20247:00 amRNSTrading Update
15th Dec 202310:15 amRNSResult of AGM
15th Dec 20237:00 amRNSAGM Statement
22nd Nov 20237:00 amRNSNotice of Annual General Meeting
25th Oct 20237:00 amRNSDirector/PDMR Shareholding
24th Oct 20237:01 amRNSAward of Options under LTIP
24th Oct 20237:00 amRNSAppointment of Interim Finance Director
18th Oct 20237:00 amRNSDirectorate Change
17th Oct 20237:00 amRNSFinal Results
11th Oct 20237:00 amRNSNotice of Results
7th Sep 20237:00 amRNSPartnership with Morrama
30th Aug 20237:00 amRNSAgreed changes to Concert Party
15th Aug 20237:00 amRNSSalistick™ to be launched in Tesco
6th Jul 20237:00 amRNSTrading Update
19th Jun 20237:00 amRNSLaunch of Salistick™ saliva pregnancy test
31st Mar 20237:00 amRNSInterim Results
24th Mar 202312:30 pmRNSNotice of Results
20th Mar 20237:00 amRNSSenzo & Abingdon enter into strategic partnership
7th Mar 20237:00 amRNSAppDx® granted further patent
1st Mar 20237:00 amRNSDirector Share Transfer to Trust
28th Feb 20239:05 amRNSSecond Price Monitoring Extn
28th Feb 20239:00 amRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSTrading Update
19th Dec 202210:29 amRNSResult of AGM
19th Dec 20227:01 amRNSAward of Options under new LTIP Scheme
19th Dec 20227:00 amRNSAGM Statement
24th Nov 20229:05 amRNSSecond Price Monitoring Extn
24th Nov 20229:00 amRNSPrice Monitoring Extension
24th Nov 20227:00 amRNSPreliminary Results
23rd Nov 20227:00 amRNSNotice of AGM and Notice of Results
10th Oct 202211:06 amRNSSecond Price Monitoring Extn
10th Oct 202211:00 amRNSPrice Monitoring Extension
10th Oct 20227:00 amRNSFurther re. Outcome of Judicial Review
7th Oct 20225:16 pmRNSFurther re. Outcome of Judicial Review
7th Oct 20224:41 pmRNSSecond Price Monitoring Extn
7th Oct 20224:36 pmRNSPrice Monitoring Extension
7th Oct 20223:29 pmRNSOutcome of Judicial Review
7th Oct 20222:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.